Notice of Intent to Sole Source
HT941025N0016
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), San Diego, intends to negotiate and award a firm fixed price contract for Hematology Analyzer in accordance with Federal Acquisition Regulation (FAR) 13.501(a) Sole Source acquisitions and FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to:
Sysmex America, Inc.
577 Aptakisic RD
Lincolnshire, Illinois 60069-4325
The North American Industry Classification System (NAICS) code for this requirement is 334516 - Analytical Laboratory Instrument Manufacturing; the business size standard is 1,000 Employees. The Product Service Code (PSC) is 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
The objective of this sole source award is to procure Sysmex XN550 Hematology Analyzer capable of performing the Complete Blood Count (CBC) with six-part WBC Differential. The CBC is a test panel that is requested by a credentialed provider which provides information about the cells in a patient’s blood. A clinical laboratory scientist performs the requested testing and provides the requesting provider with results of the patient’s CBC. The CBC includes a white blood cell count, red blood cell count, hemoglobin, hematocrit, red blood cell indices (information on red blood cell size and hemoglobin content), a platelet count as well as a white blood cell differential (neutrophils, lymphocytes, monocytes, basophils, immature granulocytes, and eosinophils are enumerated).
Supplies requirement:
(1) Sysmex XN550 Hematology Analyzer Lease
Complete Blood Count (CBC): 4,160 tests per year
Period of Performance will start 01 April 2025 to 31 March 2026 for base year and will include four (4) option years and 6-month option extension.
Base Period: 01 April 2025 to 31 March 2026
Option Period 1: 01 April 2026 to 31 March 2027
Option Period 2: 01 April 2027 to 31 March 2028
Option Period 3: 01 April 2028 to 31 March 2029
Option Period 4: 01 April 2029 to 31 March 2030
6-Month Option Extension: 01 April 2030 to 31 October 2030
Sysmex America, Inc. is the Original Equipment Manufacturer (OEM) of the XN550 Hematology Analyzer and sole proprietor of the requested reagents and consumables. These items are proprietary to Sysmex America Inc.
Sysmex is the only vendor that manufactures a clinical hematology analyzer that samples <26 uL of blood, performs patient reportable immature granulocytes as part of a 6-part diff utilizing fluorescent flow cytometry technology. These features provide the critical capability to detect cancer cells, allowing the medical community the ability to begin treatment immediately, all without purchasing an additional license or require additional reagents. Additionally, the Sysmex XN-550 analyzer meets the following dimensions and weight (17.72” W X 25.98” D X 17.72 H”/ 116.84 lbs) that will fit on the lab's limited countertop space. Service for the equipment is also required by the vendor as, the vendor is familiar with the extensive technical, physical and performance requirements of the analyzer.
The work shall be performed at:
Joint Base Pearl Harbor-Hickam (JBPHH) Air Force Base (AFB), Hawaii.
15th Medical Group - Clinical Laboratory Department
755 Scott Circle
JBPHH, HI 96853
Based on market research, Sysmex America, Inc. is the only source that can meet the Government’s minimum requirements for XN550 Hematology Analyzer.
This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the required supplies to JBPHH. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.
If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to April L. Burbage at april.l.burbage.civ@health.mil. The closing date for challenges is no later than 10:00am Pacific Time, 13 December 2024.
